Use of pramipexole

PDMED_PRAMIPEXOLE

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N04BC05

10077

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

5328

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

5328

diagram downward connector

Include endpoints None

5328

diagram downward connector
PDMED_PRAMIPEXOLE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 5328 3251 2077
Unadjusted prevalence (%) 1.50 1.64 1.32
Mean age at first event (years) 61.64 60.42 63.56

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 2.51 [1.94, 3.24] 1.6e-12 704
15 years 0.01 1.57 [1.23, 2.00] 3.1e-4 380
5 years 0.00 3.21 [2.59, 3.98] 1.7e-26 265
1 year 0.00 2.42 [1.68, 3.49] 1.9e-6 37

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: PDMED_PRAMIPEXOLE – Use of pramipexole
GWS hits:

Survival analyses between endpoints

Plot

before Use of pramipexole
after Use of pramipexole

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of pramipexole